Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AgfiledCriticalBayer Schering Pharma Ag
Publication of UY31708ApublicationCriticalpatent/UY31708A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Producto farmacéutico combinado trifásico que comprende 24 unidades de dosificación diarias consecutivas en sus tres fases que comprende, en cada fase del producto trifásico, entre 6 y 10 unidades de dosificación diarias, en donde la cantidad de drospirenona en cada dosificación diaria de cada fase es la misma y está comprendida entre 1,5 y 3,0 mg, y la cantidad de 17B (beta)-estradiol aumenta de 1,0 mg en cada unidad de dosificación en la primera fase a una cantidad de 2,0 mg de 17B (beta)-estradiol en la tercera fase.Three-phase combined pharmaceutical product comprising 24 consecutive daily dosage units in its three phases comprising, in each phase of the three-phase product, between 6 and 10 daily dosage units, wherein the amount of drospirenone in each daily dosage of each phase is the same and is between 1.5 and 3.0 mg, and the amount of 17B (beta) -estradiol increases from 1.0 mg in each dosage unit in the first phase to an amount of 2.0 mg of 17B ( beta) -estradiol in the third phase.
UY0001031708A2008-03-132009-03-13
NEW REGIME OF DROSPIRENONA / 17B-ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR APPLICATION
UY31708A
(en)
COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION.
COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION.
Compounds derived from imidazo [1,2-a] pyridine, allosteric modulators of mglur2 receptors; pharmaceutical composition comprising said compounds; and its use in the preparation of medicaments to treat disorders of the central nervous system.
Alkylated piperazine derivative compounds; pharmaceutical composition that includes them; process to prepare the pharmaceutical composition; kit and use in the treatment of immune disorders, cancer, cardiovascular diseases, inflammation, among others.
Pharmaceutical combination comprising a) an antiepileptic selected from pregabalin or oxcarbazepine and b) vitamins selected from i) vitamin b12, ii) vitamin b1 and b12, with the exception of methylcobalamin and benfothiamine; pharmaceutical composition; and its use to treat or prevent moderate to severe pain; parts kit
DERMATOLOGICAL PHARMACEUTICAL COMPOSITION, OF TOPICAL APPLICATION, IN THE FORM OF A CREAM, GEL, Ointment, SOLUTION, EMULSION THAT INCLUDES 1A 99% OF PENTOXYPHILINE, 0.1 TO 80% OF BASE CREAM AND 0.1 to 75% OF LIPOSOMES, USEFUL FOR ROSACEA , DISORDERS WITH PHOTOSENSIBILE